1. Home
  2. BMEA vs FIRY Comparison

BMEA vs FIRY Comparison

Compare BMEA & FIRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Biomea Fusion Inc.

BMEA

Biomea Fusion Inc.

N/A

Current Price

$1.96

Market Cap

140.3M

Sector

Health Care

ML Signal

N/A

Logo Firy Inc. Class A Common Stock

FIRY

Firy Inc. Class A Common Stock

N/A

Current Price

$9.78

Market Cap

127.2M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
BMEA
FIRY
Founded
2017
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
140.3M
127.2M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
BMEA
FIRY
Price
$1.96
$9.78
Analyst Decision
Strong Buy
Analyst Count
6
0
Target Price
$9.83
N/A
AVG Volume (30 Days)
1.8M
134.4K
Earning Date
05-12-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
69.19
N/A
EPS
N/A
N/A
Revenue
N/A
$104,496,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
12.52
52 Week Low
$0.87
$7.92
52 Week High
$2.99
$14.12

Technical Indicators

Market Signals
Indicator
BMEA
FIRY
Relative Strength Index (RSI) 72.89 48.41
Support Level $1.17 $9.35
Resistance Level $2.00 $10.71
Average True Range (ATR) 0.16 0.58
MACD 0.04 -0.02
Stochastic Oscillator 86.18 37.20

Price Performance

Historical Comparison
BMEA
FIRY

About BMEA Biomea Fusion Inc.

Biomea Fusion Inc is a a clinical stage diabetes and obesity medicines company focused on the discovery and development of oral, small molecule drugs to treat and improve the lives of patients with diabetes, obesity, and other metabolic diseases. It operate as an organization centered on two of its core drug candidate development programs: (i) icovamenib, its clinical program's drug candidate, currently being developed as an orally bioavailable, and selective, covalent inhibitor of menin in two clinical and multiple preclinical studies, investigating icovamenib's potential in type 1 and type 2 diabetes, as well as its impact in obesity, and (ii) BMF-650, its investigational, next-generation oral glucagon-like peptide-1 GLP-1 receptor agonist in development for the treatment of obesity.

About FIRY Firy Inc. Class A Common Stock

Firy Inc, formerly Skillz Inc is a two-sided mobile gaming platform that connects developers with competitive players. Its reportable segments are: the Skillz segment and the RZR segment. Skillz segment's highlights include Monetize Through Competitions, Player Matching, Cross-Platform Support, Comprehensive Analytics, and Focus on Game Development. Aarki is a performance marketing platform that enables advertisers to acquire, retain, and monetize users across mobile, connected television (CTV), and other digital channels. Some of the games available on its platform are Dominoes Gold, Blackout Bingo, 21 Blitz, and Solitaire Cube, among others. It generates the majority of its revenue from the Skillz segment. Geographically, the company derives its key revenue from the United States.

Share on Social Networks: